SPHERA FUNDS MANAGEMENT LTD. - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 33 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q2 2017$2,759,000
+941.1%
833,633
+1216.3%
0.47%
+1321.2%
Q3 2014$265,00063,3310.03%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q3 2017
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 3,586$15,0000.01%
THOMPSON DAVIS & CO., INC. 1,500$6,0000.01%
Psagot Value Holdings Ltd. 39,115$166,0000.01%
GUARDIAN CAPITAL ADVISORS LP 10,000$41,0000.01%
Virtu KCG Holdings LLC 41,537$177,0000.01%
D'Orazio & Associates, Inc. 1,000$4,0000.00%
SIMPLEX TRADING, LLC 7,703$32,0000.00%
NORTHERN TRUST CORP 34,223$145,0000.00%
GROUP ONE TRADING, L.P. 2,180$9,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 73,366$311,0000.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders